Spyre Therapeutics
Preeyam Patel, PhD, holds a Doctor of Philosophy in Microbiology and Immunology from the University of Alabama at Birmingham, obtained in 2016, and a Bachelor's Degree in Clinical Laboratory Science from the University of North Carolina at Chapel Hill, earned in 2011. With extensive experience in the biopharmaceutical industry, Preeyam currently serves as Principal Scientist in Translational Sciences at Spyre Therapeutics. Previous positions include Senior Scientist at IO Biotech and Latticon Antibody Therapeutics, as well as Scientist at Salubris Biotherapeutics. Additionally, Preeyam has contributed to the field through peer review services at Enago (Crimson Interactive).
This person is not in any teams
Spyre Therapeutics
Spyre Therapeutics combines best-in-class antibody engineering, rational therapeutic combinations, and precision immunology approaches to maximize efficacy, safety, and convenience of treatments for inflammatory bowel disease.